title: Effect of intracerebroventricular and systemic injections of caerulein, a CCK analogue, on electrical self-stimulation and its interaction with the CCKA receptor antagonist, L-364,718 (MK-329).
abstract: Systemic administration of caerulein (10-100 micrograms/kg SC), a potent analogue of cholecystokinin, caused a profound dose-related depression of variable-interval self-stimulation, followed by progressive recovery within 60 min. Intracerebroventricular injection of caerulein (3-1000 ng) was not more effective than systemic injection, while injections into the nucleus accumbens (3-100 ng bilaterally) were without detectable effect. Systemic injections of L-364,718 (70-700 micrograms/kg IP), a specific competitive antagonist of CCKA ("peripheral-type") receptors, had no effect on self-stimulation when given alone. When given in combination with caerulein, L-364,718 (200 micrograms/kg IP) significantly reduced the inhibitory effect of caerulein (30 micrograms/kg SC); however, this dose, and higher doses of L-364,718, failed to confer complete protection. It is concluded that self-stimulation performance may be subject to modulation by CCK receptors distributed predominantly in the peripheral nervous system and that some but not all of these receptors are CCKA receptors.
authors.affiliation: Department of Biochemistry, Charing Cross and Westminster Medical School, London, UK.
authors.forename: M H
authors.initials: MH
authors.lastname: Hamilton
authors.forename: I C
authors.initials: IC
authors.lastname: Rose
authors.forename: L J
authors.initials: LJ
authors.lastname: Herberg
authors.forename: J S
authors.initials: JS
authors.lastname: de Belleroche
mesh_terms: D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology*; D002108:Ceruletide / Q000008:administration & dosage / Q000494:pharmacology*; D002766:Cholecystokinin / Q000037:antagonists & inhibitors*; D020109:Devazepide; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D007267:Injections; D007276:Injections, Intraventricular; D008297:Male; D009714:Nucleus Accumbens; D051381:Rats; D011949:Receptors, Cholecystokinin / Q000378:metabolism*; D012653:Self Stimulation / Q000187:drug effects*
chemical_list: D001570:Benzodiazepinones; D011949:Receptors, Cholecystokinin; D002108:Ceruletide; D002766:Cholecystokinin; D020109:Devazepide